{"id":"W2554650236","doi":"10.1016/j.ijrobp.2016.11.006","title":"A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Temozolomide; Radiation therapy; Clinical endpoint; Internal medicine; Progression-free survival; Oncology; Dacarbazine; Confidence interval; Phases of clinical research; Surgery; Adjuvant; Neoadjuvant therapy; Adjuvant therapy; Chemotherapy; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001613269,0.002051807,0.003677054,0.0005910897,0.0005519878,0.001237757,0.001193273,0.001312431,0.004159782],"category_scores_gemma":[0.001136714,0.001080502,0.001768951,0.00066729,0.001652922,0.001676865,0.0005589579,0.004073644,0.000931896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001736759,"about_ca_system_score_gemma":0.003029894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002495063,"about_ca_topic_score_gemma":0.008999784,"domain_scores_codex":[0.999468,0.0002153892,0.00002750553,0.0001320982,0.00003580493,0.0001210967],"domain_scores_gemma":[0.9992766,0.0001048688,0.00009490074,0.00008152326,0.00003309231,0.000409024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9246966,0.03146277,0.001557889,0.0003110234,0.0007502966,0.00006921807,0.0001799182,0.001743463,0.01183558,0.0002068287,0.00135688,0.02582968],"study_design_scores_gemma":[0.6477982,0.3429775,0.00459101,0.00002306273,0.0005020324,0.00009676965,0.00006773163,0.0008563914,0.001449717,0.0002227056,0.001379095,0.00003592435],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944646,0.001223185,0.0003555428,0.0005778946,0.0003177682,0.001340067,0.0005511727,0.00006853292,0.001101333],"genre_scores_gemma":[0.9889364,0.001741047,0.001817562,0.0007294953,0.0002655738,0.00242039,0.001687253,0.00005153547,0.002350835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004159782,"threshold_uncertainty_score":0.01391584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01893306942305737,"score_gpt":0.3293139816825363,"score_spread":0.3103809122594789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}